EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Sialic acids modulate immune responses in cancer: Therapeutic opportunities

Eleanor E Bashian, James C Paulson, Peng Wu

Journal of Biological Chemistry · 2026-04 · 302 (4) · 111245

DOI: 10.1016/j.jbc.2026.111245 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Biological Chemistry, 2026-04. Verfasst von Eleanor E Bashian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biology, The Scripps Research Institute, La Jolla, California, USA; Department of Immunology and Microbiology, T…. Hauptthemen laut MEDLINE: Neoplasms, Sialic Acids. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 248 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health, G1 Therapeutics, US Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of therapies that boost antitumor immunity has transformed cancer treatment. While the efficacy of traditional therapies, such as chemotherapy and radiation therapy, is limited by toxicity and resistance, forms of immunotherapy, including immune checkpoint blockade therapies and engineered cellular therapies, have shown unprecedented success for certain patient populations. Despite these advances, therapeutic resistance remains a significant barrier, and alternative therapies are needed to overcome immune evasion mechanisms. One prominent evasive mechanism utilized by tumor cells is hypersialylation, the overexpression of glycans capped with sialic acid on the cell surface. This review focuses on the immunosuppressive role of sialic acid in cancer and highlights opportunities to target sialic acid and its binding proteins, offering a promising therapeutic perspective to counteract resistance and improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsSialic AcidsHumansAnimalsImmunotherapy

Stichwörter der Autor:innen

Immune evasionSelectinsSiglecscancer immunotherapycheckpointglycan-targeted therapiesglycoimmunehypersialylationsialic acid

Substanzen

Sialic Acids

Autor:innen und Institutionen

  • Department of Molecular and Cellular Biology, The Scripps Research Institute, La Jolla, California, USA; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA.
  • Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA. Electronic address: jpaulson@scripps.edu.
  • Department of Molecular and Cellular Biology, The Scripps Research Institute, La Jolla, California, USA. Electronic address: pengwu@scripps.edu.

Förderung

  • National Institutes of Health
  • G1 Therapeutics
  • US Department of Defense

Zitieren

APA

Bashian, E. E., Paulson, J. C., & Wu, P. (2026). Sialic acids modulate immune responses in cancer: Therapeutic opportunities. Journal of Biological Chemistry, 302(4), 111245. https://doi.org/10.1016/j.jbc.2026.111245

Vancouver

Bashian EE, Paulson JC, Wu P. Sialic acids modulate immune responses in cancer: Therapeutic opportunities. Journal of Biological Chemistry. 2026;302(4):111245. doi:10.1016/j.jbc.2026.111245

BibTeX
@article{Bashian2026,
  author = {Bashian, Eleanor E and Paulson, James C and Wu, Peng},
  title = {Sialic acids modulate immune responses in cancer: Therapeutic opportunities},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  volume = {302},
  number = {4},
  pages = {111245},
  doi = {10.1016/j.jbc.2026.111245}
}
Kostenlos starten →